ACHN up +4.15% percent Today $ACHN High is at 14.35 and the

New Post Public Reply Private Reply Replies (0) Message Board

Nov 14, 2014 at 1:35 PM

ACHN up +4.15% percent Today $ACHN High is at 14.35 and the Low 13.51 with current volume of 2,382,305.

Recent News posted below.

Achillion Pharmaceuticals ACHN other info.
http://investorshangout.com/Achillion-Pharmac...CHN-53213/

ACHN Achillion Pharmaceuticals Recent Headline News

Nasdaq stocks posting largest percentage increases
AP - Thu Nov 13, 5:05PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
ESCA: 13.28 (-0.24), IMDZ: 35.80 (-0.17), OLED: 27.50 (+0.30), FUEL: 18.54 (-0.66), CZR: 16.88 (+0.37), NTIC: 20.00 (-0.75), RESN: 7.19 (unch), OREX: 5.63 (-0.23), VBFC: 22.00 (+0.95), FLML: 12.86 (-0.53), ACHN: 13.79 (+0.30), RDI: 11.98 (unch), AMOT: 18.95 (-0.32), SUSQ: 13.08 (+0.02), RDIB: 12.00 (-0.04)

Profit taking sinks Achillion
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 12:48PM CST

ACHN: 13.79 (+0.30)

5 Momentum Stocks Currently on the Move with More Potential Upside
at The Street - Thu Nov 13, 11:34AM CST
Achillion, Groupon, Orexigen, Rackspace and TG Therapeutics have had strong recent moves and are showing no sign of slowing.
OREX: 5.63 (-0.23), RAX: 43.83 (+0.50), ACHN: 13.79 (+0.30), TGTX: 14.01 (+0.14), GRPN: 7.83 (+0.06)

Will Achillion Pharmaceuticals (ACHN) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 6:25AM CST
Will Achillion Pharmaceuticals (ACHN) Continue to Surge Higher?
ACHN: 13.79 (+0.30)

Achillion Pharmaceuticals: Still Bullish, But Taking Profits
Dr. Paul Nunzio DeSantis, Pharm.D - Seeking Alpha - Wed Nov 12, 4:06PM CST
By Dr. Paul Nunzio De Santis (Pharm.D.) Entry: $9.86 10/2/14 Take Profits: $14.45 11/12/14 Hold 10-20% of profits into event for M&A upside. Achillion (NASDAQ: ACHN ) has been a stellar performer since we wrote about it on October 2nd- up...
ACHN: 13.79 (+0.30), MRK: 58.97 (-0.57), ABBV: 63.75 (+0.12)

Achillion Pharmaceuticals (ACHN) Stock Rises on Positive Hepatitis C Drug Results
at The Street - Wed Nov 12, 10:57AM CST
Shares of Achillion Pharmaceuticals (ACHN) continued to rise Wednesday after the company reported encouraging interim results from a Phase II study of its hepatitis C drug ACH-3102.
ACHN: 13.79 (+0.30)

Biotech Stock Roundup: Gilead, AbbVie Score at Liver Meeting, Dendreon Files for Bankruptcy - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Nov 12, 7:48AM CST
Companies like AbbVie (ABBV), Gilead (GILD) and Achillion (ACHN) had a strong presence at the annual Liver Meeting.
VRTX: 112.26 (-0.46), GILD: 102.01 (-2.19), ACHN: 13.79 (+0.30), DNDN: 0.12 (-0.01), AMGN: 157.53 (-3.32), ABBV: 63.75 (+0.12), REGN: 396.11 (-6.52)

This Tiny Biotech Is Piggybacking on Gilead Sciences, Inc.'s Success
Todd Campbell, The Motley Fool - Motley Fool - Wed Nov 12, 7:43AM CST
Source: Gilead Sciences. Developing drugs that help established blockbusters work better is a major trend in biotechnology. It's a lower-stakes game because drug developers only need to show that their products can improve upon existing therapies,...
GILD: 102.01 (-2.19), ACHN: 13.79 (+0.30), MRK: 58.97 (-0.57)

Most active Nasdaq-traded stocks
AP - Tue Nov 11, 5:02PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
FB: 74.63 (+0.38), ACHN: 13.79 (+0.30), DNDN: 0.12 (-0.01), CMCSK: 53.80 (-0.23), ARCP: 8.70 (-0.11), ZNGA: 2.71 (-0.02), MSFT: 49.60 (-0.01), INTC: 33.89 (+0.21), GRPN: 7.83 (+0.06), CMCSA: 53.96 (-0.34), AAPL: 113.95 (+1.13), CSCO: 26.20 (+0.52)

Achillion Jumps on Encouraging Data on its HCV Candidate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 4:10PM CST
Shares of Achillion Pharmaceuticals (ACHN) soared over 27% after the company reported encouraging interim results on ACH-3102.
JNJ: 108.26 (-0.81), GILD: 101.99 (-2.21), ACHN: 13.79 (+0.30), AMAG: 33.95 (-0.29)

Why Is Gilead Always Holding The Ace? A Prediction Of The Future HCV Market And What Analysts Aren't Talking About
Pharma Doc - Seeking Alpha - Tue Nov 11, 10:13AM CST
No matter when you've followed Gilead (NASDAQ: GILD ) over the past decade, they always seem to be holding the ace. Whether in the HIV arena or now in HCV, the Gilead management is always one step ahead and is planning to dominate its market. Gilead...
GILD: 101.99 (-2.21), ACHN: 13.79 (+0.30), MRK: 58.97 (-0.57), ABBV: 63.75 (+0.12), BMY: 57.84 (+0.04)

Gilead presents Harvoni data
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 10:03AM CST

JNJ: 108.26 (-0.81), GILD: 101.99 (-2.21), ACHN: 13.79 (+0.30), CNAT: 7.11 (-0.04), MRK: 58.97 (-0.57), RGLS: 17.43 (-0.31), ABBV: 63.75 (+0.12), BMY: 57.84 (+0.04), ENTA: 43.97 (+0.75)

AbbVie presents HCV/HIV and liver transplant HCV data
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 9:07AM CST

JNJ: 108.26 (-0.81), GILD: 101.99 (-2.21), ACHN: 13.79 (+0.30), CNAT: 7.11 (-0.04), MRK: 58.97 (-0.57), RGLS: 17.43 (-0.31), ABBV: 63.75 (+0.12), BMY: 57.84 (+0.04), ENTA: 43.97 (+0.75)

Merck presents data from its investigational HCV combo
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 8:37AM CST

JNJ: 108.26 (-0.81), GILD: 101.99 (-2.21), ACHN: 13.79 (+0.30), CNAT: 7.11 (-0.04), MRK: 58.97 (-0.57), LGND: 57.39 (-0.57), RGLS: 17.43 (-0.31), ABBV: 63.75 (+0.12), BMY: 57.84 (+0.04), ENTA: 43.97 (+0.75)

Critical Alerts For Achillion Pharmaceuticals, Celldex Therapeutics, Kandi Technologies, Illumina and Advanced Micro Devices Released By InvestorsObserver
PR Newswire - Tue Nov 11, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for ACHN, CLDX, KNDI, ILMN and AMD.
KNDI: 13.56 (+0.39), AMD: 2.64 (-0.02), ACHN: 13.79 (+0.30), CLDX: 13.79 (-0.47), ILMN: 179.95 (-5.05)

Gilead presents data from three HCV drug combo studies
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 8:05AM CST

JNJ: 108.26 (-0.81), GILD: 101.99 (-2.21), ACHN: 13.79 (+0.30), CNAT: 7.11 (-0.04), LGND: 57.39 (-0.57), RGLS: 17.43 (-0.31), ABBV: 63.75 (+0.12), BMY: 57.84 (+0.04), ENTA: 43.97 (+0.75)

Alexion Pharmaceuticals Inc. (ALXN) Stock Research Links

ALXN Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wisconsin Brats Clash with Florida Citrus in Marketing Showdown

A Juicy Rivalry with Sweet and Savory Stakes You ever catch yourself watching state pride turn into a marketing showdown? That's what's cookin' with Wisconsin's Johnsonville and Florida's Natural, and believe me, this isn't just about what’s on your plate. Forget the foam fingers, here it's all about the brats and the OJ. It's like the Packers versus the Dolphins, but...

LifeSecure Expands with Starscape Agency Launch

LifeSecure's Strategic Move into the Insurance Space LifeSecure Holdings Corporation is planting new roots with its latest venture, Starscape Insurance Agency. This ain't just another splash in the kiddie pool, buddy. This is a big step in bolstering its standing in the insurance sector, focusing sharply on health insurance solutions for individuals, families, and even...

Roadrunner's Bold Move: New LTL Service and Rate Hike

When you shake up the status quo in logistics, you better be ready for the ride. Roadrunner Freight is doing just that with the launch of its first-ever outbound Canada-to-U.S. LTL service. They're shaking up a market that's been bogged down with inefficiencies for far too long. This isn't just another lane to add to a map; it's a new passage for Canadian goods, paving a...

WellBe Taps New Tech Chief to Elevate Home Care

In a move that's got the healthcare world buzzing, WellBe Senior Medical just brought in a heavyweight to steer its digital ship. They've appointed Jeffrey Brown as their new Chief Digital & Information Officer. What's shaking? Brown's stepping into the ring to tackle the age-old healthcare dilemma: making tech work smarter, not harder, especially at home. From High-Tech...

Ruth, Mickey, Superman: Morphy's Auction Smorgasbord

A Surreal Gathering of Icons and Memorabilia Who'd have thought you could snag both Babe Ruth and Mickey Mouse in one fell swoop? Well, come November 10-12, 2026, fans and collectors alike will have the opportunity at Morphy Auctions in Denver, PA. It's a dizzying array of Americana where cultural legend meets sports royalty, and we're not talking pocket change here. Babe...

Effective Youth Hockey Skills: Mastering the Basics

Laying Down the Tracks: Essential Foundations in Hockey When it comes to developing youth hockey skills, there's no magic formula or flashy trick that'll make overnight stars out of young players. According to HelloNation's recent piece featuring hockey development expert Dave Maksymiu, it’s all about going back to basics. This seems to be the memo often missed by...

Advocacy for Hiring Disabled Kidney Patients Gains Steam

Making Jobs Accessible for Kidney Patients Well, things are stirring up on Capitol Hill, and it's high time, if you ask me. The American Association of Kidney Patients (AAKP) is rallying hard for a bipartisan bill that could change the landscape for folks grappling with kidney diseases and disabilities. You’ve got Reps Pete Sessions and Steny Hoyer pushing this American...

Gemmy's Orchestra of Lights Op. 2 Unveils New Show

Jazzing Up the Holidays with Gemmy's Latest Innovation Just when you thought holiday displays couldn't get more extravagant, along comes Gemmy with its latest wonder—the Orchestra of Lights™ Op. 2. Exclusively hitting Lowe's shelves, this isn't your average set of twinkling bulbs. It's an all-out sensory assault, mixing tunes straight out of yuletide hit lists with...

Gildan Activewear Faces 18.8% Hit Amid Securities Suit

Gildan's Channel Stuffing Allegations If July showers bring August flowers, then what do June allegations bring? A stock nosedive, if you’re Gildan Activewear. Investors woke up June 16, 2026, to a harrowing drop, with shares slipping nearly 19%. It's the kind of gut-punch that makes one wonder if summer vacation is over before it even starts. Jehoshaphat Research...

Galien Recognizes Kerry for Transformative Global Health Work

Kerry's Legacy: A Symbol of Global Unity In the ever-thickening jungle of geopolitics and global health, it's rare to find a beacon as steadfast as John Kerry. This year, The Galien Foundation saw fit to honor him with the 2026 Roy Vagelos Pro Bono Humanum Award for Global Health Equity. This ain't just some shiny trinket—it’s a testament to his lifetime of ripping...